Home › NDC Lookup › Labelers › Teva Pharmaceuticals Usa, Inc.

Teva Pharmaceuticals Usa, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 51759 (Teva Pharmaceuticals Usa, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

37
Package NDCs
46
Products
46
Active listings
0
Discontinued
5
Ingredients
0
Therapeutic classes
4
Dosage forms
11
With NADAC pricing

Portfolio

Top ingredients
adalimumab-ryvk 14
risperidone 14
ustekinumab-aekn 14
fremanezumab-vfrm 2
Eculizumab-aagh 2
By dosage form
INJECTION, SOLUTION 16
KIT 14
INJECTION, SUSPENSION, EXTENDED RE... 14
INJECTION 2

Browse records — 46 products

Drug / product Billing NDC NADAC / unit Status
Adalimumab-ryvk KIT Teva · NDC 51759-0311-58 · 1 KIT in 1 CARTON (51759-311-58) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-313-30) * .4 mL in 1 POUCH (65517-0002-1) 51759-0311-58 — On market View →
Adalimumab-ryvk KIT Teva · NDC 51759-0310-59 · 2 KIT in 1 CARTON (51759-310-59) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-312-30) * .4 mL in 1 POUCH (65517-0002-1) 51759-0310-59 — On market View →
Adalimumab-ryvk KIT Teva · NDC 51759-0360-02 · 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-368-21) * .4 mL in 1 POUCH (65517-0002-1) 51759-0360-02 — On market View →
Adalimumab-ryvk KIT Teva · NDC 51759-0361-17 · 1 KIT in 1 CARTON (51759-361-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH 51759-0361-17 — On market View →
AJOVY fremanezumab-vfrm 225 mg/1.5mL INJECTION Teva · NDC 51759-0204-10 · 1 SYRINGE, GLASS in 1 CARTON (51759-204-10) / 1.5 mL in 1 SYRINGE, GLASS 51759-0204-10 $508.507 /unit · NADAC On market View →
AJOVY fremanezumab-vfrm 225 mg/1.5mL INJECTION Teva · NDC 51759-0202-10 · 1 CONTAINER in 1 CARTON (51759-202-10) / 1.5 mL in 1 CONTAINER 51759-0202-10 $508.171 /unit · NADAC On market View →
EPYSQLI Eculizumab-aagh 300 mg/30mL INJECTION, SOLUTION Teva · NDC 51759-0208-13 · Q5151 · 1 VIAL, SINGLE-DOSE in 1 CARTON (51759-208-13) / 30 mL in 1 VIAL, SINGLE-DOSE 51759-0208-13 — On market View →
EPYSQLI Eculizumab-aagh 300 mg/30mL INJECTION, SOLUTION Teva · NDC 51759-0208-13 · Q5151 · 1 VIAL, SINGLE-DOSE in 1 CARTON (51759-208-13) / 30 mL in 1 VIAL, SINGLE-DOSE 51759-0208-13 — On market View →
Selarsdi ustekinumab-aekn 45 mg/.5mL INJECTION, SOLUTION Teva · NDC 51759-0505-13 · Q9998 · 1 VIAL in 1 CARTON (51759-505-13) / .5 mL in 1 VIAL 51759-0505-13 — On market View →
Selarsdi ustekinumab-aekn 90 mg/mL INJECTION, SOLUTION Teva · NDC 51759-0607-32 · Q9998 · 1 TRAY in 1 CARTON (51759-607-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 51759-0607-32 — On market View →
Selarsdi ustekinumab-aekn 130 mg/26mL INJECTION, SOLUTION Teva · NDC 51759-0708-13 · Q9998 · 1 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL, GLASS 51759-0708-13 — On market View →
Selarsdi ustekinumab-aekn 90 mg/mL INJECTION, SOLUTION Teva · NDC 51759-0607-32 · Q9998 · 1 TRAY in 1 CARTON (51759-607-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 51759-0607-32 — On market View →
Selarsdi ustekinumab-aekn 130 mg/26mL INJECTION, SOLUTION Teva · NDC 51759-0708-13 · Q9998 · 1 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL, GLASS 51759-0708-13 — On market View →
Selarsdi ustekinumab-aekn 45 mg/.5mL INJECTION, SOLUTION Teva · NDC 51759-0505-13 · Q9998 · 1 VIAL in 1 CARTON (51759-505-13) / .5 mL in 1 VIAL 51759-0505-13 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0523-21 · 1 KIT in 1 CARTON (51759-523-21) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-634-31) * .4 mL in 1 POUCH (65517-0002-1) 51759-0523-21 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0412-22 · 2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH 51759-0412-22 $478.649 /unit · NADAC On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0386-22 · 2 KIT in 1 CARTON (51759-386-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE (51759-497-31) * .4 mL in 1 POUCH (65517-0002-1) 51759-0386-22 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0274-17 · 1 KIT in 1 CARTON (51759-274-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-384-21) * .4 mL in 1 POUCH 51759-0274-17 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0402-02 · 2 KIT in 1 CARTON (51759-402-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) 51759-0402-02 $499.119 /unit · NADAC On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0412-22 · 2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH 51759-0412-22 $478.649 /unit · NADAC On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0386-22 · 2 KIT in 1 CARTON (51759-386-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE (51759-497-31) * .4 mL in 1 POUCH (65517-0002-1) 51759-0386-22 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0523-21 · 1 KIT in 1 CARTON (51759-523-21) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-634-31) * .4 mL in 1 POUCH (65517-0002-1) 51759-0523-21 — On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0402-02 · 2 KIT in 1 CARTON (51759-402-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) 51759-0402-02 $499.119 /unit · NADAC On market View →
Simlandi adalimumab-ryvk KIT Teva · NDC 51759-0274-17 · 1 KIT in 1 CARTON (51759-274-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-384-21) * .4 mL in 1 POUCH 51759-0274-17 — On market View →
Ustekinumab-aekn 90 mg/mL INJECTION, SOLUTION Teva · NDC 51759-0710-32 · Q9998 · 1 TRAY in 1 CARTON (51759-710-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 51759-0710-32 — Discontinued View →
Ustekinumab-aekn 45 mg/.5mL INJECTION, SOLUTION Teva · NDC 51759-0709-32 · Q9998 · 1 TRAY in 1 CARTON (51759-709-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS 51759-0709-32 — Discontinued View →
Ustekinumab-aekn 90 mg/mL INJECTION, SOLUTION Teva · NDC 51759-0414-32 · Q9998 · 1 TRAY in 1 CARTON (51759-414-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 51759-0414-32 — On market View →
Ustekinumab-aekn 45 mg/.5mL INJECTION, SOLUTION Teva · NDC 51759-0413-32 · Q9998 · 1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS 51759-0413-32 — On market View →
Ustekinumab-aekn 45 mg/.5mL INJECTION, SOLUTION Teva · NDC 51759-0413-32 · Q9998 · 1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS 51759-0413-32 — On market View →
Ustekinumab-aekn 90 mg/mL INJECTION, SOLUTION Teva · NDC 51759-0414-32 · Q9998 · 1 TRAY in 1 CARTON (51759-414-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS 51759-0414-32 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.